Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1923.2000 -55.40 (-2.80%)
NSE Jul 08, 2025 12:33 PM
Volume: 1.1M
 

logo
Lupin Ltd.
03 Jul 2025
1923.20
-2.80%
buy
by BOB Capital Markets Ltd.
Target: 2626 | Upside : 36.5%
BOB Capital Markets Ltd.
LPC's OTC carve-out won't significantly impact financials, but aims to double OTC sales by sharpening focus
 
Number of FII/FPI investors increased from 964 to 979 in Mar 2025 qtr.
More from Lupin Ltd.
Recommended
Market trades flat, Mukul Agrawal adds J&K Bank to his portfolio in Q1FY26
Trendlyne Marketwatch | 08 Jul 2025, 12:34PM
As IPO fever hits new high, Crizac and three other listings on the horizon
| 07 Jul 2025, 05:34PM
Lupin expects normalization by September quarter
| 17 Apr 2020